-
PDF
- Split View
-
Views
-
Cite
Cite
M Klevjer, J.C Saether, E Vesterbekkmo, G Giskeoedegaard, T Bathen, B Gigante, S Gjaere, M Myhra, R Wiseth, E Madssen, A Bye, Cardiac Exercise Research Group (CERG) , Lipoprotein subfraction LDL-5 and the presence of coronary atherosclerosis, European Heart Journal, Volume 41, Issue Supplement_2, November 2020, ehaa946.1353, https://doi.org/10.1093/ehjci/ehaa946.1353
- Share Icon Share
Abstract
Coronary artery disease (CAD) has high mortality rates and is a frequent cause of death globally. Serum lipids play a pivotal role in the development of atherosclerosis, and elevated levels of total cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides are well known risk factors of cardiovascular disease (CVD). However, there are limitations in the ability to predict CVD risk, which has led to an increased clinical interest in identifying novel risk markers. With the advances in lipidomic technology, lipoprotein subfractions may provide additional information that is missing in today's evaluation of CVD risk. Lipoprotein subfractions differ in size and density, and recent studies suggest that high density of small LDL particles provide a greater risk for CVD.
To investigate whether lipoprotein subfractions are associated with the presence and extent of coronary atherosclerosis.
Fasting serum samples from 60 participants with suspected stable CAD were collected before scheduled coronary angiography, and analysed by nuclear magnetic resonance (NMR). The presence and extent of atherosclerosis were quantified by the Gensini Score. Participants were classified into one of three Gensini groups based on severity (<20.5, normal; 20.6–30, non-significant CAD; >30.1, significant CAD).
A three-way ANOVA, adjusted for statin-use and sex, revealed statistically significant differences (p<0.005) in LDL-5 particle number, LDL-5 triglycerides, and LDL-5 phospholipids between the Gensini groups. In addition, significant differences (p<0.005) were found in the ratios apolipoprotein A/apolipoprotein B and LDL cholesterol/HDL cholesterol between the Gensini groups. All significant variables, identified by the three-way ANOVA, displayed the highest levels in the Gensini group with significant CAD.
Despite no difference in the traditional clinical measurements (total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides), NMR-lipidomics revealed significant differences in LDL-5 between the Gensini groups. Interestingly, our results reveal that those with significant CAD have a higher density of small LDL subfractions.
Type of funding source: Foundation. Main funding source(s): Norwegian Health Association, The Liaison Committee for Education, Research and Innovation in Central Norway